| # | Drug | Count |
|---|---|---|
| 0 | EVOLOCUMAB | 202 |
| 1 | ROSUVASTATIN | 87 |
| 2 | EZETIMIBE | 80 |
| 3 | ASPIRIN | 57 |
| 4 | ASPIRIN 325 MG | 54 |
| 5 | ASPIRIN 81 MG | 54 |
| 6 | ATORVASTATIN CALCIUM | 54 |
| 7 | ALIROCUMAB | 34 |
| 8 | INCLISIRAN | 34 |
| 9 | METFORMIN | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 1 | INCLISIRAN | 34 | 0.0040 |
| 2 | LOMITAPIDE MESYLATE | 12 | 0.0032 |
| 3 | BEMPEDOIC ACID | 5 | 0.0019 |
| 4 | GIVINOSTAT | 1 | 0.0016 |
| 5 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 6 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 7 | ALIROCUMAB | 34 | 0.0013 |
| 8 | EVOLOCUMAB | 202 | 0.0012 |
| 9 | EZETIMIBE | 80 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 235 | 0.0091 |
| 1 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 6 | 0.0018 |
| 2 | Dietary Cholesterol Absorption Inhibitor [EPC] | 85 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 5 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 6 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 2 | 0.0003 |
| 7 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Ergot Derivative [EPC] | 1 | 0.0002 |